Ali AlBahar: The Immunologic Complexity Behind ABO Blood Grouping
Ali AlBahar, Transfusion Medicine Specialist, Hematology and Blood Transfusion Researcher (MSc) at Ministry of Health Saudi Arabia, shared a post on LinkedIn:
“The ABO system is more than just A, B, AB, or O.
Under the microscope, most red cells may look identical…
but immunologically, they can be completely different.
The presence or absence of ABO antigens plays a critical role in:
- Transfusion compatibility
- Immune recognition
- Patient safety
- Hemolytic risk
An ABO-incompatible transfusion is not simply a ‘blood group mismatch’ —
it can trigger a rapid, severe, and potentially fatal hemolytic transfusion reaction.
Even patients with the same ABO group may still require antibody screening and crossmatching, especially if they have a history of transfusion, pregnancy, or unexpected antibodies.
Safe transfusion starts with understanding ABO…
and is completed by proper compatibility testing.”

Stay updated with Hemostasis Today.
-
Aug 31, 2026, 14:03Adil Aftab: Anticoagulation in CKD – Key Updates from the 2026 ESC Guidelines
-
Aug 31, 2026, 14:01Isa Oboirien: Why Might Factor XI Inhibition Work Differently in Stroke and ACS?
-
Aug 31, 2026, 13:55Mike Morrissey: Advancing Europe’s Cardiovascular Health Agenda at ESC Congress 2026
-
Aug 31, 2026, 13:44Penilla Gunther: Patient Voices Take Center Stage in Cardiovascular Prevention at ESC Congress 2026
-
Aug 31, 2026, 13:42Mohamed Saleh Gomaa: Master the Latest in PE Management
-
Aug 31, 2026, 13:38Lyn Kleinbach-Reilly: A New Standard for Coagulation Testing in Neonatal Care
-
Aug 31, 2026, 13:36Rafael Gomes: Can Prasugrel Replace Ticagrelor in ACS Treatment?
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients